Agm Group Holdings Inc. (AGMH)
NASDAQ (CM) NASDAQ (CM) Primary 
Genflow Biosciences Plc Announces Result of AGM
LONDON, UNITED KINGDOM / ACCESSWIRE / June 27, 2024 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company") an emerging leader in the field of longevity research, focused on developing therapeutic solutions for the prevention of age-related diseases is pleased to announce that all resolutions proposed at the Annual General Meeting held earlier today were duly passed. Contacts Genflow Biosciences Harbor Access Dr Eric Leire, CEO Jonathan Paterson, Investor Relations +32-477-495-881 +1 475 477 9401 [email protected] Capital Plus Partners Ltd Keith Swann, +44 0203 821 6169 Jon Critchley, +44 0203 821 6168 About Genflow Founded in 2020, Genflow Biosciences Plc.
Pegasus Shareholders Approve All Matters at the 2024 AGM
VANCOUVER, BC / ACCESSWIRE / June 19, 2024 / Pegasus Resources Inc. (TSXV:PEGA)(Frankfurt:0QS2)(OTC PINK:SLTFF) (the "Company" or "Pegasus") is pleased to announce that all resolutions were passed at the Annual General Meeting held on June 18, 2024. The four nominees to be elected as directors listed in the Company's information circular dated May 14, 2024, were elected as directors of the Company for the ensuing year and the number of directors was fixed at four.
